FDA Revisits Rare Cancer Drug Approval After Unexpected Rejection Sparks Controversy
The FDA is reconsidering its decision to reject a treatment for a rare cancer after an unexpected rejection. Meanwhile, experts question the Trump adm...
Xeber.world
cancer research
- electric vehicles
- automotive industry
- Stellantis
- collector cars
- automotive history
- Limited Edition
- classic cars
- Mecum Auctions
- supercar
- Formula 1
- Donald Trump
- AI ethics
- U.S. China relations
- AI adoption
- AI regulation
- artificial intelligence
- Trump administration
- inflation
- AI governance
- AI in business
- Bitcoin
- crypto regulation
- Senate Banking Committee
- CLARITY Act
- digital assets
- Digital Asset Market Clarity Act
- Federal Reserve
- Bitcoin price
- Bitcoin ETF
- crypto market
- AI cybersecurity
- cybersecurity
- CISA
- enterprise security
- CVE-2026-41089
- CVE-2026-41096
- Canvas data breach
- Instructure
- House Homeland Security Committee
- Donald Trump
- Netflix
- late-night TV
- Disney
- Paramount
- Cannes Film Festival
- Stephen Colbert
- Prime Video
- Jimmy Kimmel
- Marvel
- climate change
- renewable energy
- energy policy
- AI data centers
- geothermal energy
- Fervo Energy
- U.S. energy policy
- Strait of Hormuz
- Jason Bordoff
- Texas drought
- Subnautica 2
- Phasmophobia
- gaming news
- R.E.P.O.
- Forza Horizon 6
- FC 26
- Subnautica 2 tips
- Subnautica 2 guide
- Alan Wake event
- Destructoid
- FDA
- public health
- Marty Makary
- Trump administration
- healthcare policy
- Kyle Diamantas
- hantavirus
- health policy
- FDA leadership
- gene therapy
- Donald Trump
- Trump administration
- Supreme Court
- gerrymandering
- Iran war
- Voting Rights Act
- 2024 election
- Republican Party
- Virginia Supreme Court
- redistricting
- AI ethics
- climate change
- Elon Musk
- OpenAI
- ChatGPT
- tech industry
- Tesla
- remote sensing
- AI in the workplace
- generative AI
Breakthrough Study Reveals Why Pancreatic Cancer Is So Hard to Treat and How New Therapies Could Change Outcomes
New research from the University of Rochester Medicine uncovers why pancreatic cancer evades detection and treatment, revealing a key gene, Dec2, that...
Study Reveals How Extra Chromosomes Drive Aggressive Cancer Spread
New research from Tulane University shows that extra chromosomes in cancer cells trigger a stress response, enhancing their mobility and ability to in...
FDA Launches AI-Powered Initiative to Accelerate Clinical Trials with Real-Time Data Review
The FDA has announced a new effort to enhance clinical trial efficiency by reviewing real-time data from trials conducted by AstraZeneca and Amgen. Th...
How MG2’s Swing for the Cure Unites Communities Against Cancer
Cancer affects nearly everyone, but MG2’s Swing for the Cure turns shared experiences into action. Since 1999, the annual event has raised over $2 mil...
Groundbreaking Study Reveals How Tumors Use Glutathione as Fuel, Opening New Avenues for Cancer Treatment
A study published in Nature reveals that cancer cells consume the antioxidant glutathione as fuel, challenging prior assumptions about its role. Resea...
How the heart's constant beating may naturally suppress cancer, mouse study reveals
Heart disease and cancer are the top killers in the U.S., yet cancer rarely spreads to the heart. Researchers now suggest the organ's constant beating...
Daily Aspirin Fails to Reduce Colorectal Cancer Risk, Study Finds
A large-scale review reveals that daily low-dose aspirin does not significantly lower colorectal cancer risk and may increase bleeding risks. Experts...
Key Insights from AACR: Chinese Biotech, Oncology Communication Gaps, and Breakthroughs in RAS Inhibitors
The final edition of STAT's AACR in 30 seconds newsletter highlights critical discussions on Chinese biotech, oncology communication challenges, and g...
Revolution Medicines Unveils Promising KRAS Drug Data and Novel RAS Inhibitor at AACR 2024
Revolution Medicines presented strong clinical trial data for its next-generation KRAS inhibitor, daraxonrasib, in advanced pancreatic cancer at the A...
Revolution Medicines’ KRAS Drug Shows Strong Results at AACR 2024; NCI Director Addresses Funding Concerns
Revolution Medicines’ experimental KRAS drug, daraxonrasib, doubled survival rates in second-line pancreatic cancer patients compared to chemotherapy....
Metformin May Match Exercise Benefits in Prostate Cancer Patients by Boosting 'Exercise Molecule'
A new study reveals that the diabetes drug metformin may mimic a key effect of exercise in prostate cancer patients by increasing levels of an 'exerci...
Breakthrough Genetic Sensor Enables MRIs to Detect Molecular-Level Changes in Real Time
A new genetically encoded sensor developed by UC Santa Barbara researchers could revolutionize MRI technology by enabling real-time visualization of m...